Study on early diagnosis of a brain structure closure in pregnancy
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study looks at what it means when a small fluid-filled space in the baby's brain closes earlier than usual during pregnancy. Researchers want to understand if this finding can predict the baby's future health and development.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and have been told your baby has an early closure of the cavum septum pellucidum (a tiny gap in the brain) on an ultrasound done between 19 weeks and 21 weeks plus 6 days of pregnancy.
- You are 18 years or older.
- You agree to sign a consent form for yourself and also for your baby to participate.
- You are receiving care at the study center in Bologna, Italy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound to examine fetal brain and spine development in pregnant women. It compares scans from pregnancies where a brain or spine issue is suspected with those from healthy pregnancies to improve understanding and diagnosis.
This trial studies whether a specific ultrasound approach can better detect problems with fetal (baby) growth in the later part of pregnancy. It may help identify concerns earlier so your care team can plan the next steps.
This study looks at how a mother's health and experiences during pregnancy may affect her baby's brain growth and early development. You and your baby would have special MRI brain scans, fill out some questionnaires, and then your child's development would be followed until they are 6 years old.
This study examines spinal fluid from babies with spina bifida to better understand a related brain condition (Chiari II malformation). The information could help improve care for future babies with this condition.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
This study looks at how a baby’s organs develop in late pregnancy, using situations where someone is already being evaluated for a possible fetal abnormality and chooses to end the pregnancy. The goal is to better understand late-stage fetal development and related causes of abnormalities.
Hear when a new Fetal Neurodevelopmental Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.